Large-scale testing (Phase 3)Study completedNCT00046748What this trial is testingEfficacy and Safety of Omalizumab in Patients With Severe Persistent AsthmaWho this might be right forAsthma Novartis Pharmaceuticals 484
Not applicableUnknownNCT02033252What this trial is testingAcupuncture for Rhinitis Complicated With AsthmaWho this might be right forAllergic RhinitisAsthma Jun-Yong Choi 30
Not applicableStudy completedNCT01147224What this trial is testingATEM (Alvesco Non-interventional Study)Who this might be right forAsthmaAllergy AstraZeneca 400
Large-scale testing (Phase 3)Study completedNCT00289874What this trial is testingMontelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED)Who this might be right forAsthma Organon and Co 421
Post-approval studies (Phase 4)Study completedNCT00870584What this trial is testingEvaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic AsthmaWho this might be right forPersistent Allergic Asthma Novartis Pharmaceuticals 271
Testing effectiveness (Phase 2)Study completedNCT03774290What this trial is testingStudy to Investigate the Effect of PBF-680 on Forced Expiratory Volume in 1 Second (FEV1) in Asthmatic PatientsWho this might be right forAsthma Palobiofarma SL 107
Large-scale testing (Phase 3)Study completedNCT01202903What this trial is testingOmalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 TherapyWho this might be right forPersistent Allergic Asthma Novartis Pharmaceuticals 616
Large-scale testing (Phase 3)Study completedNCT01007149What this trial is testingEffect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled AsthmaWho this might be right forAsthma Novartis Pharmaceuticals 79
Post-approval studies (Phase 4)Ended earlyNCT02953106What this trial is testingEffects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic RhinitisWho this might be right forAsthma, AllergicRhinitis,AllergicAllergy University of Dundee 7
Large-scale testing (Phase 3)Study completedNCT00599027What this trial is testingAn Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent AsthmaWho this might be right forAllergic RhinitisAsthma Organon and Co 51
Testing effectiveness (Phase 2)Looking for participantsNCT07342803What this trial is testingEfficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma PatientsWho this might be right forAllergic Asthma Longbio Pharma 200
Testing effectiveness (Phase 2)Ended earlyNCT01591343What this trial is testingSafety Study of Depigoid Vaccine Dermatophagoides Pteronyssinus or 50% Dermatophagoides Pteronyssinus / 50% Dermatophagoides Farinae (500 DPP/ml), to Treat Allergic Rhinitis or Rhinoconjunctivitis With or Without AsthmaWho this might be right forAllergic RhinitisRhinoconjunctivitisMild Persistent Asthma+1 more Laboratorios Leti, S.L. 8
Testing effectiveness (Phase 2)WithdrawnNCT00598104What this trial is testingSafety and Efficacy of QAX576 in Adults With Moderate Persistent Allergic AsthmaWho this might be right forAsthma Novartis
Post-approval studies (Phase 4)Study completedNCT00691873What this trial is testingStudy to Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled CorticosteroidsWho this might be right forAsthma University of Mississippi Medical Center 14
Not applicableStudy completedNCT03563521What this trial is testingIdentifying Serum Cytokine Profiles of Distinct Inflammatory Phenotypes in Severe AsthmaWho this might be right forAsthma PersistentAsthma, AllergicEosinophilic Asthma+1 more TC Erciyes University 95
Post-approval studies (Phase 4)Study completedNCT00267202What this trial is testingStudy to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic AsthmaWho this might be right forAllergic Asthma Novartis 275
Large-scale testing (Phase 3)Study completedNCT00445107What this trial is testingSINGULAIR (R) as Complementary Therapy to Fixed Association Regimen (0476-363)Who this might be right forAsthma Organon and Co 198
Large-scale testing (Phase 3)Study completedNCT00500539What this trial is testingOpen Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation.Who this might be right forAsthma Novartis 155
Post-approval studies (Phase 4)Study completedNCT01430403What this trial is testingPreventative Omalizumab or Step-up Therapy for Severe Fall ExacerbationsWho this might be right forAsthma National Institute of Allergy and Infectious Diseases (NIAID) 478
Testing effectiveness (Phase 2)Study completedNCT01437735What this trial is testingDose Finding Study for QAW039 in AsthmaWho this might be right forAsthma Novartis Pharmaceuticals 1,043